These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 28889794)

  • 1. Editorial: Computer Aided Structure-based Lead Optimization.
    Beuming T; Shi L
    Curr Top Med Chem; 2017; 17(23):2575-2576. PubMed ID: 28889794
    [No Abstract]   [Full Text] [Related]  

  • 2. In silico prediction of hERG inhibition.
    Jing Y; Easter A; Peters D; Kim N; Enyedy IJ
    Future Med Chem; 2015; 7(5):571-86. PubMed ID: 25921399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding Free Energy Calculation Using Quantum Mechanics Aimed for Drug Lead Optimization.
    Cavasotto CN
    Methods Mol Biol; 2020; 2114():257-268. PubMed ID: 32016898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of hERG closure allow novel insights into hERG blocking by small molecules.
    Schmidtke P; Ciantar M; Theret I; Ducrot P
    J Chem Inf Model; 2014 Aug; 54(8):2320-33. PubMed ID: 25000969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided design of GPCR ligands.
    Gutiérrez-de-Terán H; Keränen H; Azuaje J; Rodríguez D; Åqvist J; Sotelo E
    Methods Mol Biol; 2015; 1272():271-91. PubMed ID: 25563191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
    Deniz U; Ozkirimli E; Ulgen KO
    J Mol Graph Model; 2016 Jan; 63():110-24. PubMed ID: 26724452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification.
    Ke YY; Singh VK; Coumar MS; Hsu YC; Wang WC; Song JS; Chen CH; Lin WH; Wu SH; Hsu JT; Shih C; Hsieh HP
    Sci Rep; 2015 Jun; 5():11702. PubMed ID: 26118648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An automated docking protocol for hERG channel blockers.
    Di Martino GP; Masetti M; Ceccarini L; Cavalli A; Recanatini M
    J Chem Inf Model; 2013 Jan; 53(1):159-75. PubMed ID: 23259741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 5-Chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a Novel, Selective, and Orally Active α1D Adrenoceptor Antagonist with Antiurinary Frequency Effects: Reducing Human Ether-a-go-go-Related Gene (hERG) Liabilities.
    Sakauchi N; Kohara Y; Sato A; Suzaki T; Imai Y; Okabe Y; Imai S; Saikawa R; Nagabukuro H; Kuno H; Fujita H; Kamo I; Yoshida M
    J Med Chem; 2016 Apr; 59(7):2989-3002. PubMed ID: 26954848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial preface.
    Nilsson L; Åqvist J
    Biochim Biophys Acta; 2015 May; 1850(5):859-860. PubMed ID: 25615536
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantum-Mechanics Methodologies in Drug Discovery: Applications of Docking and Scoring in Lead Optimization.
    Crespo A; Rodriguez-Granillo A; Lim VT
    Curr Top Med Chem; 2017; 17(23):2663-2680. PubMed ID: 28685695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and development of DNA methyltransferase inhibitors using in silico approaches.
    Medina-Franco JL; Méndez-Lucio O; Dueñas-González A; Yoo J
    Drug Discov Today; 2015 May; 20(5):569-77. PubMed ID: 25526932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and molecular dynamics studies on the structure-activity relationship of fluoroquinolone for the HERG channel.
    Luo F; Gu J; Chen L; Xu X
    Mol Biosyst; 2014 Nov; 10(11):2863-9. PubMed ID: 25100024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights in the mechanism of action and inhibition of N-acylethanolamine acid amidase by means of computational methods.
    Lodola A; Rivara S; Mor M
    Adv Protein Chem Struct Biol; 2014; 96():219-34. PubMed ID: 25443959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-Aided Drug Design Methods.
    Yu W; MacKerell AD
    Methods Mol Biol; 2017; 1520():85-106. PubMed ID: 27873247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: QSAR models for computer-aided drug design and molecular docking for disorders of the central nervous system and other diseases.
    Prado-Prado F; García-Mera X
    Curr Top Med Chem; 2012; 12(16):1731-3. PubMed ID: 23030608
    [No Abstract]   [Full Text] [Related]  

  • 17. hERG channel blockade by externally applied quaternary ammonium derivatives.
    Choi KH; Song C; Shin D; Park S
    Biochim Biophys Acta; 2011 Jun; 1808(6):1560-6. PubMed ID: 21320466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connecting the virtual world of computers to the real world of medicinal chemistry.
    Glen RC
    Future Med Chem; 2011 Mar; 3(4):399-403. PubMed ID: 21452976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation study.
    Choubey SK; Jeyaraman J
    J Mol Graph Model; 2016 Nov; 70():54-69. PubMed ID: 27668885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current insights into computer-aided immunotherapeutic design strategies.
    Cai Z; Zhang G; Zhang X; Liu Y; Fu X
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):278-85. PubMed ID: 26091813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.